Literature DB >> 2774728

Transatrial membranotomy for Budd-Chiari syndrome.

C H Chang1, M C Lee, M J Shieh, J P Chang, P J Lin.   

Abstract

In a 7-year period, transatrial membranotomy was performed in 11 patients with membranous obstruction of the inferior vena cava. There were 5 men and 6 women, ranging in age from 23 to 53 years. Clinical symptoms included jaundice in 4 patients, hepatomegaly in 4, leg edema or varicose veins in 10, and venous collaterals over the abdominal and chest wall in all 11 patients. Transatrial membranotomy was performed through a median sternotomy in all patients. When inferior vena cava venography revealed that the obstruction was accompanied by long segmental thrombosis, additional dilation was performed with a Hegar dilator. There was no surgical mortality. Early operative complications included pulmonary embolism in 2 patients and bleeding requiring reoperation in 1. In a mean follow-up period of 30.6 months (range, 2 to 88 months), 9 patients had no symptoms, transient pericardial constriction developed in 1 patient and resolved 1 month later, and restenosis of the inferior vena cava developed in another patient 1 year after the first operation. This latter patient received a second transatrial membranotomy followed by percutaneous balloon angioplasty of the inferior vena cava, with a satisfactory result at 8 months follow-up. We conclude that transatrial membranotomy is an effective and safe procedure for patients with membranous obstruction of the inferior vena cava.

Entities:  

Mesh:

Year:  1989        PMID: 2774728     DOI: 10.1016/s0003-4975(10)62867-6

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  3 in total

1.  Membranous obstruction of hepatic venous flow.

Authors:  D H De; A T Pezzella; T Nguyenduy
Journal:  Tex Heart Inst J       Date:  1995

Review 2.  Hepatic venous outflow obstruction: three similar syndromes.

Authors:  Ulas-Darda Bayraktar; Soley Seren; Yusuf Bayraktar
Journal:  World J Gastroenterol       Date:  2007-04-07       Impact factor: 5.742

3.  Budd-Chiari Syndrome.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  1999-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.